'Bone lesions' diaporamas de présentation

PARA PROTEINEMIAS

PARA PROTEINEMIAS. Sheikha. Professor Anwar Sheikha MD, FRCP, FRCPath ., FCAP, FRCPA, FRCPI, FACP Senior Consultant Clinical & Lab. Hematologist Clinical Professor of Hematology University of Mississippi Medical Center, Jackson, Mississippi Professor of Hematology,

1.77k views • 153 slides

Path Slide Final Review

Path Slide Final Review. 2009. Characteritures of enamel organ, but produce no enamel Unencapsulated Locally infiltrative, do not metatasize Always radiolucent Become multilocular as they grow Can expand the jaw Islands of odontogenic EP in stroma of fibrous CT

1.22k views • 110 slides

Survivorship, Patient Engagement & Side Effect Management

Survivorship, Patient Engagement & Side Effect Management. LLS Multiple Myeloma Conference Pewaukee, WI October 5, 2013 (updated post conference) Mike Thompson, MD, PhD @ mtmdphd Medical Director Early Cancer Research Program, Patient-Centered Research Aurora Research Institute.

1.07k views • 87 slides

692 views • 53 slides

737 views • 49 slides

556 views • 40 slides

Tabuk University

793 views • 33 slides

SPECT/CT IMAGING Benefits to Clinical Nuclear Medicine

SPECT/CT IMAGING Benefits to Clinical Nuclear Medicine. The Basics. SPECT (Single Photon Emission Computerized Tomography) Computer generated three dimensional images of radioactive tracer distribution. COMPUTERIZED TOMOGRAPHY

1.65k views • 32 slides

Multiple Myeloma

317 views • 29 slides

Ex: localized tenderness at left 9th rib (7cm distanant from posterior midline) + irregularity .

43y/o male pt heavey smoker 3 packs/D present to OPD c/o localized pain at left posterior side of the chest wall for 4 months duration associated with chronic non-productive cough. No Hx of trauma. PAST Hx: unremarkable.

388 views • 27 slides

Multiple Myeloma

Multiple Myeloma. Definition: B-cell malignancy characterised by abnormal proliferation of plasma cells able to produce a monoclonal immunoglobulin (M protein) Incidence: 3 - 9 cases per 100000 population / year more frequent in elderly modest male predominance.

748 views • 27 slides

HARD TISSUE LESIONS

HARD TISSUE LESIONS . Dr Norzalina Ghazali BDentSc , BA (Ire), MClinDent (Child Dental Health) (Mal) Lecturer Faculty of Dentistry Universiti Sains Islam Malaysia (USIM) 20/12/2013. HARD TISSUE OF THE BODY. Bone, cementum , dentin and enamel

768 views • 26 slides

Table 1. Peak Age Predilection of Bone Lesions

Table 1. Peak Age Predilection of Bone Lesions. Figure 1: Diagram shows common locations of tumors and tumorlike conditions in transverse and longitudinal dimensions of a long bone.

861 views • 23 slides

PET E TUMORI NEUROENDOCRINI: NUOVI TRACCIANTI Stefano Fanti

PET E TUMORI NEUROENDOCRINI: NUOVI TRACCIANTI Stefano Fanti. 18 F-DOPA PET. Somatostatin Receptor PET. 18 F-DOPA PET. CLINICAL APPLICATIONS. NEUROLOGY: Movement disorders (Parkinson Disease). ONCOLOGY: Neuroendocrine tumors Pheochromocytoma Neuroblastoma (?). F-DOPA. FDG.

533 views • 22 slides

632 views • 22 slides

PET E TUMORI NEUROENDOCRINI: NUOVI TRACCIANTI Stefano Fanti

PET E TUMORI NEUROENDOCRINI: NUOVI TRACCIANTI Stefano Fanti. 18 F-DOPA PET. Somatostatin Receptor PET. 18 F-DOPA PET. CLINICAL APPLICATIONS. NEUROLOGY: Movement disorders (Parkinson Disease). ONCOLOGY: Neuroendocrine tumors Pheochromocytoma Neuroblastoma (?). F-DOPA. FDG.

221 views • 22 slides